Aug 2 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2019 Jun 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 113 mln 171 mln 991 mln
(-34.0 pct) (+29.4 pct) (+27.0 pct)
Operating loss 104 mln loss 35 mln loss 391 mln
Recurring loss 127 mln loss 35 mln loss 550 mln
Net loss 124 mln loss 44 mln loss 565 mln
EPS loss 14.28 yen loss 5.31 yen loss 64.76 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T